← Retour au Screener

Sector: Santé
Open in Terminal → NNOXLive chart · Key metrics · News · Smart money

Nano-X Imaging

NNOX Micro Cap

Healthcare · Medical Devices

Mis à jour: Jun 18, 2026, 22:21 UTC

1,46 €
-3.47% aujourd'hui
52W: 1,39 € – 4,97 €
52W Low: 1,39 € Position: 2% 52W High: 4,97 €

Price Chart

Indicateurs clés

P/E Ratio
Cours/Bénéfice
Forward P/E
P/E prévisionnel
P/S Ratio
8.93x
Cours/Ventes
EV/EBITDA
Valeur d'entreprise/EBITDA
Rend. dividende
Rendement annuel du dividende
Cap. boursière
101 M €
Capitalisation boursière
Croissance du CA
24%
Croissance du CA sur un an
Marge bénéficiaire
Marge nette
ROE
-45.62%
Rentabilité des capitaux propres
Beta
1.17
Sensibilité au marché
Positions vendeuses
14.59%
% du flottant vendu à découvert
Volume moyen
1,461,193
Volume quotidien moyen

Valuation Analysis

Signal
N/A
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
None
3 analysts
Avg. Price Target
6,28 €
+331.14% upside
Target Range
4,36 € – 8,38 €

About the Company

Sector: Healthcare Industry: Medical Devices Country: Israel Employees: 197 Exchange: NGM

Nano-X Imaging en bref

Nano-X Imaging (NNOX) is currently trading at 1,46 € with a market capitalization of 101 M €. The 52-week range spans from 1,39 € to 4,97 €; the current price is 70.7% below the yearly high. Year-over-year revenue growth stands at +24.0%.

💰 Dividende

Nano-X Imaging currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

3 analystes évaluent Nano-X Imaging (NNOX) au consensus : None. L'objectif de cours moyen est de 6,28 €, soit un potentiel de +331.14% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 4,36 € à 8,38 €.

Nano-X Imaging : la thèse d'investissement en détail

Nano-X Imaging (NNOX) operates in the Healthcare — specifically Medical Devices — and is headquartered in Israel. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 24% pace year-over-year, suggesting the business model continues to find new customers and pricing power.

Le scénario baissier

Short interest sits at 14.59% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

À surveiller

  • The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
  • The analyst consensus price target implies 331.14% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Points forts
  • Forte croissance du CA de 24% sur un an
  • Bilan solide avec faible endettement (D/E 5.62)
Points faibles
  • Positions vendeuses élevées (14.59%)
  • Free cash flow négatif

Aperçu technique

MM 50 jours
1,68 €
-13.47% vs. cours
MM 200 jours
2,52 €
-42.21% vs. cours
Sous le plus haut 52s
−70.7%
4,97 €
Au-dessus du plus bas 52s
+5%
1,39 €

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

Risque de marché (Bêta)
1.17 · Proche du marché
Évolue plus que le marché global
Positions vendeuses
14.59% · Élevé
% du flottant vendu à découvert
Dette/Capitaux propres
5.62 · Faible
Dette totale / capitaux propres

The data points to market-like volatility, elevated short interest (14.59%).

Trading Data

50-Day MA: 1,68 €
200-Day MA: 2,52 €
Volume: 1,457,039
Avg. Volume: 1,461,193
Short Ratio: 7.65
P/B Ratio: 0.83x
Debt/Equity: 5.62x
Free Cash Flow: -22 073 685 €

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy Nano-X Imaging?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut